The DDR Inhibitors Summit is the definitive industry forum for drug developers advancing DNA Damage Response (DDR)-targeted therapies. With PARP inhibitors now clinically validated, the field is rapidly evolving to explore novel DDR targets like ATR, CHK1/2, DNA-PK, and WEE1, alongside smarter biomarker strategies and combination approaches.
Back to All Events
Earlier Event: January 16
Genome Stability Network Annual Meeting, Cambridge, UK
Later Event: February 23
The Ubiquitin Family in Biology and Disease, Banff, AB, Canada